1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow SCCHN: new trials by email Literature Review of SCCHN trials Research Report on SCCHN
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma Combination Product: Nivolumab with Pemetrexed - SCCHN | Phase 2 | Completed | AHS Cancer Control Alberta | 6 | 2020-03-19 | 2024-06-14 |
Nivolumab (1) · Pemetrexed (1)
AHS Cancer Control Alberta (1)
Canada (1)
Hatim Karachiwala, MD FRCPC (1)
PMID 11531245, PMID 18784101, PMID 19934295, PMID 21766301, PMID 22996369, PMID 23726971, PMID 24196717, PMID 25941355, PMID 28779022, PMID 7165009